Multiple Sclerosis Journal – Experimental, Translational and Clinical
Journal Highlights
- Now discoverable in PubMedCentral.
- The open access companion journal to Multiple Sclerosis Journal.
- Articles received more than 130,000 full-text downloads in 2022.
Multiple Sclerosis Journal – Experimental, Translational and Clinical is an international, peer reviewed, open access publication that augments the potential to publish across the broad spectrum of experimental, translational and clinical topics in Multiple Sclerosis. For more information on the journal please visit the aims and scope tab.
As an open access publication, all articles are freely available online immediately upon publication. All articles are rigorously peer-reviewed, and brought to publication as rapidly as possible.
The journal is also a member of the Committee on Publication Ethics (COPE).
Submission information
Submit your manuscript today at https://mc.manuscriptcentral.com/msj-etc.
Please see the submission guidelines tab for more information on how to format your manuscript.
Open access information
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence.
The APC for this journal is 2800 USD.
Members of the American Committee for Treatment and Research in Multiple Sclerosis, the European Committee for Treatment and Research in Multiple Sclerosis, the Latin American Committee for Treatment and Research in Multiple Sclerosis, the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis or Rehabilitation in Multiple Sclerosis will receive a 75% discount on the APC.
The APC is payable when a manuscript is accepted after peer review, before it is published. The APC is also subject to taxes where applicable. Please see further details here.
Multiple Sclerosis Journal – Experimental, Translational and Clinical is an international, peer reviewed, open access publication that augments the potential to publish across the broad spectrum of experimental, translational and clinical topics in Multiple Sclerosis. It facilitates the rapid publication of high quality papers in:
- Emerging observations with translational potential not yet realized.
- Early validation of clinical outcome metrics.
- Pilot trials which may stimulate therapeutic innovation.
- Geographic focus which validate and add to existing studies.
- High specialized areas of experimental, translational and clinical research.
| Simon Broadley | Griffith University, Australia |
| Wallace Brownlee | University College London, UK |
| Declan Chard | University College London, UK |
| Jeffrey Cohen | Cleveland Clinic, USA |
| Anneke Van Der Walt | Monash University, Australia |
| Jennifer Graves | University of California, San Diego, USA |
| Anna Hedström | Karolinska Institute, Sweden |
| Ho Jin Kim | Research Institute and Hospital of National Cancer Center, Korea |
| Daniel Ontaneda | Cleveland Clinic, USA |
| Maria Pia Amato (ECTRIMS President) | Department of NEUROFARBA, University of Florence, Italy |
| Maria Rocca | IRCCS San Raffaele Scientific Institute, Italy |
| Jaume Sastre-Garriga | Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Spain |
| Ahmed Toosy | University College London, UK |
| Ho Jin Kim | Research Institute and Hospital of National Cancer Center, Korea |
| Dr. Carlos Navas | Neurologíca Clínica Colombia, Colombia |
| Prof. Bruno Stankoff | Sorbonne University Dept. of Neurology, France |
| Marcello Moccia | University College London, UK |
| Nathalie Arbour | Université de Montréal, Canada |
| Peter Arnett | Penn State University, USA |
| Georgina Arrambide | Hospital Vall d’Hebron, Spain |
| Sergio Baranzini | University of California San Francisco, USA |
| Frederik Barkhof | Vrije Universiteit, The Netherlands & University College London, UK |
| Ralph Benedict | University of Buffalo, USA |
| Jeff Bennett | University of Colorado Denver, USA |
| Simon Broadley | Griffith University, Australia |
| Peter A. Calabresi | Johns Hopkins, USA |
| Nancy Chiaravalloti | Kessler Foundation, USA |
| Olga Ciccarelli | UCL Institute of Neurology, UK |
| Manuel Comabella | Centre d'Esclerosi Multiple de Catalunya, Spain |
| Giancarlo Comi | Vita-Salute San Raffaele University and Scientific Institute, Italy |
| Jorge Correale | Institute for Neurological Research, Argentina |
| Fiona Costello | University of Calgary, Canada |
| Gary Cutter | University of Alabama at Birmingham, USA |
| Ulrik Dalgas | Aarhus University, Denmark |
| Philip De Jager | Columbia University, USA |
| Gabriele DeLuca | University of Oxford, UK |
| Suhayl Dhib-Jalbut (President ACTRIMS) | Rutgers University, New Jersey, USA |
| Ranjan Dutta | Cleveland Clinic, USA |
| Anthony Feinstein | University of Toronto, Canada |
| Peter Feys | Hasselt University, Belgium |
| Robert Fox | Cleveland Clinic, USA |
| Mark Freedman | The Ottawa Hospital-General Campus, Canada |
| Jennifer Freeman | University of Plymouth, UK |
| Stefan Gold | Clinical Neuroscience and Immunology, Berlin, Germany |
| Hanneke Hulst | VU MS Centre Amsterdam, Netherlands |
| Matilde Inglese | Mount Sinai School of Medicine, USA |
| Noriko Isobe | Kyushu University, Japan |
| Tomas Kalincik | University of Melbourne, Australia |
| Joep Killestein | VU University Medical Center, Amsterdam, Netherlands |
| Alexander Klistorner | Macquarie University, Sydney Australia |
| Daphne Kos | University of Leuven, Belgium |
| Tanja Kuhlmann | University of Münster, Germany |
| Catherine Lubetzki | Salpetriere Hospital, France |
| Ruth Ann Marrie | University of Manitoba, Canada |
| Gianvito Martino | San Raffaele Scientific Institute, Milan, Italy |
| Veronique Miron | University of Edinburgh, UK |
| Xavier Montalban | Vall d'Hebron University Hospital, Barcelona, Spain |
| Ellen Mowry | Johns Hopkins University |
| Daniel Ontaneda | Cleveland Clinic, USA |
| Maria Pia Amato (ECTRIMS President) | Department of NEUROFARBA, University of Florence, Italy |
| Anne-Louise Ponsonby | Murdoch Children’s Research Institute, University of Melbourne, Australia |
| Danny Reich | National Institutes of Health Translational Neuroradiology Unit, USA |
| Maria Rocca | IRCCS San Raffaele Scientific Institute, Italy |
| Shiv Saidha | Johns Hopkins University, USA |
| Jaume Sastre-Garriga | Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Spain |
| Menno Schooneim | Amsterdam University Medical Centres, the Netherlands |
| Allessandra Solari | IRCCS Carlo Besta Neurological Institute Foundation, Italy |
| Maria Pia Sormani | University of Genoa, Italy |
| Alan J Thompson | University College London, UK |
| Mar Tintore | Hospital Vall d’Hebron, Spain |
| Mar Tintore | Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Spain |
| Ahmed Toosy | University College London, UK |
| Carmen Tur | University College London, London, UK |
| Ann Yeh | The Hospital for Sick Children (SickKids), Canada |
Manuscript submission guidelines can be accessed on Sage Journals.